avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Bcl11a | mm10_v2_chr11_+_24078022_24078076 | 0.82 | 1.3e-09 | Click! |
Runx2 | mm10_v2_chr17_-_44735612_44735710 | 0.78 | 2.0e-08 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_-_87875524 Show fit | 33.94 |
ENSMUST00000049768.3
|
eosinophil peroxidase |
|
chr11_+_87793470 Show fit | 26.91 |
ENSMUST00000020779.4
|
myeloperoxidase |
|
chr11_+_87793722 Show fit | 25.34 |
ENSMUST00000143021.2
|
myeloperoxidase |
|
chr7_+_143005046 Show fit | 25.24 |
ENSMUST00000009396.6
|
tetraspanin 32 |
|
chr4_-_46404224 Show fit | 21.61 |
ENSMUST00000107764.2
|
hemogen |
|
chr18_-_35649349 Show fit | 20.89 |
ENSMUST00000025211.4
|
marginal zone B and B1 cell-specific protein 1 |
|
chr5_+_90768511 Show fit | 20.69 |
ENSMUST00000031319.6
|
pro-platelet basic protein |
|
chr7_+_143005677 Show fit | 19.86 |
ENSMUST00000082008.5
ENSMUST00000105925.1 ENSMUST00000105924.1 |
tetraspanin 32 |
|
chr7_+_143005638 Show fit | 19.77 |
ENSMUST00000075172.5
ENSMUST00000105923.1 |
tetraspanin 32 |
|
chr7_-_142661858 Show fit | 18.83 |
ENSMUST00000145896.2
|
insulin-like growth factor 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.9 | 79.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
17.4 | 52.3 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
5.0 | 39.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
11.4 | 34.1 | GO:0002215 | defense response to nematode(GO:0002215) |
2.9 | 23.5 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
1.2 | 22.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
4.2 | 20.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
6.1 | 18.3 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
0.2 | 18.1 | GO:0042100 | B cell proliferation(GO:0042100) |
3.3 | 16.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.7 | 70.7 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
4.0 | 63.7 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 56.2 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 26.5 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
6.1 | 18.3 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.7 | 17.7 | GO:0031528 | microvillus membrane(GO:0031528) |
4.2 | 16.8 | GO:0044194 | cytolytic granule(GO:0044194) |
1.5 | 16.5 | GO:0042629 | mast cell granule(GO:0042629) |
1.1 | 15.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 14.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 79.2 | GO:0004601 | peroxidase activity(GO:0004601) |
1.1 | 62.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
2.2 | 28.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 24.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
2.0 | 23.9 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.2 | 21.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.3 | 19.5 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 17.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
1.8 | 16.0 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.4 | 15.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 60.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.5 | 36.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.6 | 34.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.7 | 23.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.6 | 23.3 | PID EPO PATHWAY | EPO signaling pathway |
0.4 | 22.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 19.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.8 | 14.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 14.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.8 | 13.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 36.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.7 | 33.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 25.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.1 | 22.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.4 | 17.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.2 | 16.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 16.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 15.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 15.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.3 | 13.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |